|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Mental Health (NIMH) |
| Information provided by: | National Institute of Mental Health (NIMH) |
| ClinicalTrials.gov Identifier: | NCT00073645 |
Purpose
This study will compare the effectiveness of family- and peer-oriented therapy in treating children with anxiety disorders.
| Condition | Intervention | Phase |
|
Anxiety Disorders |
Behavioral: Cognitive Behavior Therapy |
Phase I |
| MedlinePlus related topics: | Anxiety |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
| Official Title: | Therapy Specificity and Mediation in Family and Group CBT |
| Estimated Enrollment: | 250 |
| Study Start Date: | July 2002 |
| Estimated Study Completion Date: | June 2007 |
Data suggest that individual Cognitive Behavior Therapy (CBT) is effective in reducing anxiety disorders in children. The incorporation of family and peers in a CBT treatment program may be more effective in reducing anxiety symptoms than CBT alone because a child's environment affects the development, course, and outcome of childhood psychopathology and functional status. This study will evaluate the effectiveness of family and peer involvement in CBT treatment.
Children and their parents will be randomly assigned to one of two treatment conditions: Family/Parents CBT (FCBT) or Peer/Group CBT (GCBT) for 14 to 16 weekly sessions. Parent-child relationships are the focus of the FCBT. Parents will be trained to manage their children's anxiety and avoidant behaviors by increasing acceptance and warmth toward their children. Children in the GCBT group will be trained to be more helpful and positive toward other children through role-playing activities. Interviews, questionnaires, and behavior observation tasks will be used to assess participants. All participants will be assessed at pretreatment, post-treatment, and at yearly follow-up visits for 5 years.
Eligibility
| Ages Eligible for Study: | 8 Years to 14 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
Exclusion Criteria:
Contacts and Locations| United States, Florida | |||||
| Florida International University | Recruiting | ||||
| Miami, Florida, United States, 33174 | |||||
| Contact: Patricia R. Alvarez 305-348-2494 Patricia.Alvarez@fiu.edu | |||||
| Principal Investigator: Wendy K. Silverman, PhD | |||||
| Sub-Investigator: William Kurtines, PhD | |||||
More Information
| Study ID Numbers: | R01 MH63997, DSIR 84-CTS |
| First Received: | December 2, 2003 |
| Last Updated: | March 13, 2007 |
| ClinicalTrials.gov Identifier: | NCT00073645 |
| Health Authority: | United States: Federal Government |
|
|